Cargando…

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus

AIMS: Left ventricular (LV) thrombus is increasingly detected in patients with and without ischaemic heart disease due to the increased availability of cardiac magnetic resonance imaging. Risk factors include anterior ST elevation myocardial infarction, delayed reperfusion therapy, and non‐ischaemic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iqbal, Hansa, Straw, Sam, Craven, Thomas P., Stirling, Katherine, Wheatcroft, Stephen B., Witte, Klaus K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524136/ https://www.ncbi.nlm.nih.gov/pubmed/32583975 http://dx.doi.org/10.1002/ehf2.12718

Ejemplares similares

Improving the management of left ventricular thrombus in a tertiary cardiology centre: a quality improvement project
por: Rahunathan, Nithusa, et al.
Publicado: (2023)

Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
por: Huang, Lei, et al.
Publicado: (2022)

Assessment of non‐vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus
por: Li, Shunhui, et al.
Publicado: (2021)

Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus
por: Kido, Kazuhiko, et al.
Publicado: (2021)

Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis
por: Shrestha, Dhan B., et al.
Publicado: (2023)

Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis
por: Kitano, Tetsuji, et al.
Publicado: (2021)

Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus
por: Kitano, Tetsuji, et al.
Publicado: (2023)

Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis
por: Xuan, He, et al.
Publicado: (2021)

Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials
por: Chen, Yanming, et al.
Publicado: (2022)

Direct oral anticoagulant use in left ventricular thrombus
por: Ali, Zafar, et al.
Publicado: (2020)

Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis
por: Michael, Faith, et al.
Publicado: (2021)

Resolution of Left Ventricular Thrombus by Vitamin K Antagonist after Failed Treatment with Apixaban in Hemodialysis Patient: Case Report
por: Alenazi, Saleem, et al.
Publicado: (2023)

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
por: Zhang, Qian, et al.
Publicado: (2023)

The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus
por: Feng, Mingjun, et al.
Publicado: (2021)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
por: Kumano, Osamu, et al.
Publicado: (2021)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

Efficacy of direct oral anticoagulants on the resolution of left ventricular thrombus—A case series and literature review
por: Bahmaid, Reem A, et al.
Publicado: (2019)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
por: Reers, Stefan, et al.
Publicado: (2018)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
por: Fedorov, Kateryna, et al.
Publicado: (2021)

Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study
por: Baker, Ross I., et al.
Publicado: (2023)

Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
por: Dalia, Tarun, et al.
Publicado: (2021)

Hyperhomocysteinemia and Left Ventricular Thrombus
por: Raut, Monish S, et al.
Publicado: (2017)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

The Role of Anticoagulation in Post-COVID-19 Concomitant Stroke, Myocardial Infarction, and Left Ventricular Thrombus: A Case Report
por: Iqbal, Phool, et al.
Publicado: (2021)

Treatment of left ventricular thrombus after myocardial infarction: need longer or lifetime use of anticoagulants?
por: Du, Chong, et al.
Publicado: (2021)

Dataset for the study of the effect of anticoagulation in the incidence of stroke and other outcomes in patients with left ventricular thrombus
por: Lorente-Ros, Álvaro, et al.
Publicado: (2023)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
por: Camilleri, Eleonora, et al.
Publicado: (2021)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery
por: Manfredini, Mattia, et al.
Publicado: (2021)

Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants
por: Pradhan, Akshyaya, et al.
Publicado: (2023)

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
por: Toorop, Myrthe M. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2bqpnhdrfj0estmmcs20kf0eil